News Conference News AHA 2022 New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events Yael L. Maxwell November 07, 2022
News Conference News AHA 2022 STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends Todd Neale November 07, 2022
News Conference News AHA 2022 ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD Shelley Wood November 06, 2022
News Conference News AHA 2022 Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions Yael L. Maxwell November 01, 2022
News Daily News STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden Caitlin E. Cox October 31, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2022 Shelley Wood October 31, 2022
News Daily News More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials Michael O'Riordan October 28, 2022
News Daily News Early Data Suggest Plant-Based Foods Could Improve Outcomes in HF L.A. McKeown October 26, 2022
News Daily News Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients Todd Neale October 26, 2022
News Daily News Cardiopulmonary Tests in Long COVID Offer Some Clues, Pose More Questions L.A. McKeown October 21, 2022
News Daily News SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes Michael O'Riordan October 18, 2022
News Daily News STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF Shelley Wood October 17, 2022
News Daily News FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs Michael O'Riordan October 17, 2022
News Daily News Guideline Guidance: Practical Tips for Finding, Triaging Chest Pain in the ED Yael L. Maxwell October 12, 2022
News Daily News COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review Todd Neale October 12, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Daily News COAPT Risk Score Useful in Predicting Outcomes in Functional MR Michael O'Riordan October 05, 2022
News Daily News Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use L.A. McKeown October 05, 2022